• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA details how pharma companies can counter health misinformation

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 11, 2024 at 11:02: PM
via Now, the FDA has released an updated draft guidance for the pharma and medical device industries that explains how companies can address misinformation about their approved products.

article source
 

<



Similar threads

cafead
FDA Reveals More Details on 22 CAR-T Secondary Cancer Cases
Replies
0
Views
171
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA details switch to electronic filings for 510(k), de novo submissions
Replies
0
Views
118
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA details plan to end emergency use authorizations for devices
Replies
0
Views
117
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA details approach for finding optimal dosages for new cancer drugs
Replies
0
Views
150
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Beam details reasons for FDA hold on base editing cancer therapy
Replies
0
Views
175
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote